Combivir
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background In the Treatment Options Preservation Study (TOPS) trial, 4 or 7 days of Combivir (CBV; zidovudine/ lamivudine) with…
To the Editor: Pandemic (H1N1) 2009 virus first appeared in March 2009 in Mexico. In June 2009, a pandemic was declared by the…
ABSTRACT The CCR102881 (ASCENT) study evaluated the antiviral activity of the novel CCR5 entry inhibitor aplaviroc plus a fixed…
A 25-year-old HIV-infected woman participating in a study of the effects of hormonal contraception on HIV disease progression was…
To detect and characterize polymerase gene (pol) polymorphisms and mutation patterns in HIV-1C-infected Batswana patients treated…
I-172 6 Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in…
SummaryAbstractSaquinavir is a potent and highly selective HIV protease inhibitor. Initially formulated as a hard-gel capsule…
Editor,—The non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz is a recent addition to the armamentarium available…